The Effectiveness of Intravitreal Avastin Injection for CRVO
NCT01678248 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2012-09-03
Summary
to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion
Conditions
- Central Retinal Vein Occlusion
Sponsors & Collaborators
-
Ziv Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion
NCT06416241 ·Status: COMPLETED ·Phase: PHASE4
-
Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
NCT01053858 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Injections by Nurses and Physicians Compared
NCT02359149 ·Status: COMPLETED ·Phase: NA
-
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
NCT00370851 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
NCT00556348 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
NCT00423059 ·Status: COMPLETED ·Phase: NA
-
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
NCT01012973 ·Status: COMPLETED ·Phase: PHASE3
-
Optic Nerve and Retinal Functions With Bevacizumab
NCT01361828 ·Status: COMPLETED
-
Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
NCT01256580 ·Status: WITHDRAWN ·Phase: NA
-
Study of the Long-Term Effect of Frequent Anti-VEGF Dosing on Retinal Function in Patients With Neovascular AMD
NCT00533689 ·Status: UNKNOWN ·Phase: PHASE3
-
Visual Outcome After Vitrectomy With Subretinal tPA Injection
NCT05196139 ·Status: COMPLETED
-
Systemic Avastin Therapy in Age-Related Macular Degeneration
NCT00531024 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravitreal Avastin in Proliferative Retinopathies
NCT00564148 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)
NCT01178697 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion
NCT02033031 ·Status: COMPLETED ·Phase: PHASE3
-
Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
NCT01581411 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
NCT00596505 ·Status: COMPLETED
-
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
NCT01327222 ·Status: COMPLETED ·Phase: PHASE3
-
Central Vein Occlusion Study (CVOS)
NCT00000131 ·Status: COMPLETED ·Phase: PHASE3
-
Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma
NCT01051583 ·Status: COMPLETED ·Phase: PHASE2
-
Ocular Discomfort Assessment After Intravitreal Injections
NCT02806830 ·Status: COMPLETED ·Phase: NA
-
Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
NCT05514925 ·Status: UNKNOWN ·Phase: PHASE4
-
Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
NCT02797704 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
NCT04601701 ·Status: UNKNOWN ·Phase: NA
-
Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
NCT01716026 ·Status: COMPLETED ·Phase: PHASE3